Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)

NCT01104181 is registered in ClinicalTrials.gov with Laser Surgery Care as lead sponsor.

NCT NCT01104181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01104181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)
Lead sponsor
Laser Surgery Care
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2010
Completion date
March 31, 2011
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anal canal hpv infection diagnosis, anal cancer, anal dysplasia diagnosis